Use of rFXIII in Treatment of Congenital FXIII Deficiency, a Prospective Multi-centre Observational Study

NCT01862367 · clinicaltrials.gov ↗

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Congenital FXIII Deficiency

Interventions

DRUG: catridecacog

Sponsor

Novo Nordisk A/S